These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 6195797

  • 21. The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives.
    Schatzl G, Madersbacher S, Lang T, Marberger M.
    J Urol; 1997 Jul; 158(1):105-10; discussion 110-1. PubMed ID: 9186334
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Changes in serum levels of lipid peroxidation products and ceruloplasmin in patients with benign prostatic hyperplasia in uncomplicated and complicated periods after transurethral electro-resection].
    Tarasov NI, Volchegorskiĭ IA, Vasil'kov AIu.
    Urologiia; 2001 Jul; (1):16-8. PubMed ID: 11233223
    [Abstract] [Full Text] [Related]

  • 25. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
    Gupta N, Sivaramakrishna, Kumar R, Dogra PN, Seth A.
    BJU Int; 2006 Jan; 97(1):85-9. PubMed ID: 16336334
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Vapor resection: a good alternative to standard loop resection in the management of prostates >40 cc.
    Gupta NP, Doddamani D, Aron M, Hemal AK.
    J Endourol; 2002 Dec; 16(10):767-71. PubMed ID: 12542882
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparison of fluid absorption between transurethral enucleation and transurethral resection for benign prostate hyperplasia.
    Ran L, He W, Zhu X, Zhou Q, Gou X.
    Urol Int; 2013 Dec; 91(1):26-30. PubMed ID: 23571450
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Transurethral resection of prostate: early versus delayed removal of catheter.
    Durrani SN, Khan S, Ur Rehman A.
    J Ayub Med Coll Abbottabad; 2014 Dec; 26(1):38-41. PubMed ID: 25358214
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate.
    Ornstein DK, Rao GS, Smith DS, Andriole GL.
    J Urol; 1997 Mar; 157(3):880-3; discussion 883-4. PubMed ID: 9072591
    [Abstract] [Full Text] [Related]

  • 38. Hyponatraemia after transurethral resection of the prostate.
    Agius AM, Cutajar CL.
    J R Coll Surg Edinb; 1991 Apr; 36(2):109-12. PubMed ID: 2051406
    [Abstract] [Full Text] [Related]

  • 39. Serum PSA and PAP measurements discriminating patients with prostate carcinoma from patients with nodular hyperplasia.
    Shih WJ, Collins J, Mitchell B, Wierzbinski B.
    J Natl Med Assoc; 1994 Sep; 86(9):667-70. PubMed ID: 7525979
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.